Renal Parameters | Lipid Profile | |||
Sodium | 135–145 mmol/L | Total cholesterol | <200 mg/dL | |
Potassium | 3.5–5 mmol/L | Triglyceride | <150 mg/dL | |
Bicarbonate | 22–29 mmol/L | LDL cholesterol | <100 mg/dL | |
Chloride | 95–105 mmol/L | HDL cholesterol | >60 mg/dL | |
Urea | 15–40 mg/dL | |||
Creatinine | 0.7–1.4 mg/dL (males) 0.5–1.1 mg/dL (females) | |||
Bone Profile | Liver Function Tests (LFTs) | |||
Calcium | 8.3–10.4 mg/dL | Bilirubin total | 0.5–1 mg/dL | |
Albumin | 3.5–5.0 g/dL | Bilirubin direct | 0.1–0.5 mg/dL | |
Phosphate | 2.5–4.6 mg/dL | Protein | 6.0–8.5 g/dL | |
Alkaline phosphatase | 40–125 U/L | Albumin | 3.5–5.0 g/dL | |
Vitamin D (25 OHD3) | >30 ng/mL | Alanine amino-transferase (ALT or SGPT) | 5–35 U/L | |
Parathyroid hormone | 8–74 pg/mL | Aspartate amino transferase (AST or SGOT) | 8–40 U/L | |
24-hr urinary calcium | 50–300 mg/24 hr | Alkaline phosphatase | 40–125 U/L |
DIABETES |
Glucose | ||
Fasting (AC) | Normal | <100 mg/dL |
Impaired fasting glucose | 100–125 mg/dL | |
Diabetes mellitus | ≥126 mg/dL | |
2 hr postmeal (PC) | Normal | <140 mg/dL |
Impaired glucose tolerance | ||
Diabetes mellitus | ≥200 mg/dL | |
HbA1c | ||
Normal | <5.7% | |
Prediabetes | 5.7–6.4% | |
Diabetes | ≥6.5% | |
C-Peptide | 1.1–5.0 ng/mL | |
Antiglutamic acid decarboxylase (GAD) antibody | <5.0 U/mL | |
Anti-islet cell antibody | <7.5 U/mL | |
Insulin (fasting) | 0–30 µU/mL | |
Urine microalbumin | <30 mg/g creatinine | |
Urine protein/creatinine | <0.21 mg/mg | |
24-hr urine protein | 50–150 mg/24-hr |
HORMONE ASSAYS |
Thyroid | |||||
Total thyroxine (TT4) | 4.5–12.5 µg/dL | ||||
Free thyroxine (FT4) | 0.8–2.0 ng/dL | Gonadal hormones | |||
Total T3 | 90–190 ng/dL | Follicle stimulating hormone (FSH) (Women) | |||
Thyroid stimulating hormone (TSH) | 0.3–4.5 mIU/L | Follicular phase | 2.8–11.3 mIU/mL | ||
Thyroid antibodies - | Mid-cycle | 5.8–21 mIU/mL | |||
Antimicrosomal (TPO) antibodies | <50 IU/mL | Luteal phase | 1.2–9 mIU/mL | ||
Antithyroglobulin antibodies | <100 IU/mL | Postmenopausal | 21.7–153 mIU/mL | ||
Thyroglobulin (Post-thyroidectomy) | <1 ng/mL | (Men) | 0.7–11.1 mIU/mL | ||
Calcitonin | 0–50 pg/mL | ||||
Luteinizing hormone (LH) (Women) | |||||
Adrenal | Follicular phase | 1.1–11.6 mIU/mL | |||
17 OH-progesterone | Mid-cycle | 17–77 mIU/mL | |||
Men | 0.4–3.3 ng/mL | Luteal phase | 0.0–14.7 mIU/mL | ||
Women (Follicular phase) | 0.1–1.2 ng/mL | Postmenopausal | 11.3–39.8 mIU/mL | ||
(Luteal phase) | 0.4–4.8 ng/mL | (Men) | |||
Dehydroepiandrosterone sulfate (DHEAS) | |||||
Men | 80–560 µg/dL | Estradiol | |||
Women | 35–430 µg/dL | Follicular phase | 0–0.587 nmol/L | ||
Plasma renin | 2.8–39.9 µIU/mL | Luteal phase | 0.1–0.91 nmol/L | ||
Progesterone | |||||
Aldosterone | Follicular phase | 1.00–3.80 nmol/L | |||
Supine | 10–160 pg/mL | Mid-cycle | 1.70–50 nmol/L | ||
Upright | 40–310 pg/mL | Luteal Phase | 2.30–56.60 nmol/L | ||
Urine metanephrine | <350 mg/day | ||||
Urine normetanephrine | <600 mg/day | Prolactin | |||
Women | 1.9–25.0 ng/mL | ||||
Pituitary | Men | 2.5–17 ng/mL | |||
Human growth hormone (basal) | 0–5.0 ng/mL | ||||
(1 hour postglucose) | <0.4 ng/mL | Testosterone | |||
(2 hour postglucose) | <0.4 ng/mL | ||||
Women | 50–120 ng/dL | ||||
Insulin like growth factor-1 (IGF-1) | |||||
10 years | 88–452 ng/mL | ||||
20 years | 127–424 ng/mL | Men (20–49 yrs) | 270–1030 ng/dL | ||
26–30 years | 117–329 ng/mL | ||||
(>50 yrs) | 212–755 ng/dL | ||||
46–50 years | 94–252 ng/mL | ||||
66–70 years | 69–200 ng/mL | ||||
Adreno corticotrophic hormone (ACTH) | 0–46 pg/mL | ||||
Sex hormone binding globulin (SHBG) | |||||
Cortisol | |||||
Basal (morning) | 7–25 µg/dL | Women | 26.1–110 nmol/L | ||
Post-Synacthen (30 and 60 min) | >20 µg/dL | ||||
Men | 14.5–48.4 nmol/L | ||||
Post-Dexa | <1.8 µg/dL | ||||
24-hr urinary free cortisol (UFC) | 10–55 µg/24-hr | Inhibin A | <97 pg/mL | ||
Anti-Müllerian hormone (AMH) | 2.0–6.8 ng/mL |